Expectorant, antitussive, anti-inflammatory activities and compositional analysis of Aster tataricus
Bibliographic Data
| ID | 14740974 |
|---|---|
| Authors | Ping Yu (0000-0002-7910-9396, China Pharmaceutical University), Si Cheng (0000-0002-0728-2878, China Pharmaceutical University), Juan Xiang (0000-0003-1000-645X, China Pharmaceutical University), Bin Yu (0000-0001-6980-7345, China Pharmaceutical University), Mian Zhang (0000-0003-2165-1446, corresponding author), Chaofeng Zhang (0000-0002-1504-305X, China Pharmaceutical University), Xianghong Xu (0000-0003-0739-5423, corresponding author) |
| Year | 2015 |
| Volume | 164 |
| Pages | 328-333 |
| Publication date | 2015-04-01 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Journal of Ethnopharmacology (JOURNAL) |
| Journal identifiers | ISSN: 0378-8741 • E-ISSN: 1872-7573 |
| Publisher | Elsevier BV (PUBLISHER) |
| DOI | 10.1016/j.jep.2015.02.036 |
| PMID | 25701752 |
| OpenAlex | W1998731055 |
| Language | EN |
| Citations received | 6 |
| References cited | 19 |
Chromatography · Expectorant · Phenol red · Traditional medicine · Chemistry · Medicine · Natural product bioactivities and synthesis · Phytochemical compounds biological activities · Phytochemistry and Biological Activities · Pharmacology
A comprehensive and systematic review on botany, traditional applications, phytochemistry, pharmacology, and resource protection of genus Aster L.
Analysis of Phenolic and Flavonoids of Wild Ephedra Alata Plant Extracts by Lc/Pda and Lc/MS and Their Antioxidant Activity
Anti-Cancer Activity of Aster Tataricus on SCC-9 Human Oral Squamous Carcinoma
Development of natural products for anti-PD-1/PD-L1 immunotherapy against cancer
Zhisou powder suppresses airway inflammation in LPS and CS-induced post-infectious cough model mice via TRPA1/TRPV1 channels
Antitussive, expectorant, and anti-inflammatory effects of Adenophorae Radix powder in ICR mice
| Unique citing works | 6 |
|---|---|
| Citations per year | 0,67 |
| Citation span | 2017 - 2026 (10) |
| Citation velocity | current |
| Highly cited | No |
| Citation types | Neutral: 3 |